Liu M, Liu Y, Song S, Qiao Q, Liu J, Xie Y
Vaccines (Basel). 2025; 13(1).
PMID: 39852870
PMC: 11769188.
DOI: 10.3390/vaccines13010091.
Clark T, Tregoning J, Lister H, Poletti T, Amin F, Nguyen-Van-Tam J
Clin Microbiol Rev. 2024; 37(4):e0002524.
PMID: 39360831
PMC: 11629632.
DOI: 10.1128/cmr.00025-24.
Grohskopf L, Ferdinands J, Blanton L, Broder K, Loehr J
MMWR Recomm Rep. 2024; 73(5):1-25.
PMID: 39197095
PMC: 11501009.
DOI: 10.15585/mmwr.rr7305a1.
Abrams E, Zafack J, Jensen C, Bettinger J, Top K, Hildebrand K
Can Fam Physician. 2024; 70(1):10-12.
PMID: 38262763
PMC: 11126281.
DOI: 10.46747/cfp.700110.
Diaz M, Vidal Oribe I, DElia Torrence D, Hernandez Alfonso P, Alarcon Gallardo E
Curr Treat Options Allergy. 2022; 9(3):273-291.
PMID: 35910462
PMC: 9308858.
DOI: 10.1007/s40521-022-00313-6.
Statement on Seasonal Influenza Vaccine for 2013-2014: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI).
Can Commun Dis Rep. 2019; 39(ACS-4):1-37.
PMID: 31701948
PMC: 6802458.
DOI: 10.14745/ccdr.v39i00a04.
Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate-Two randomized Phase II clinical trials in 18 to 49 and ≥50 years old adults.
Pillet S, Couillard J, Trepanier S, Poulin J, Yassine-Diab B, Guy B
PLoS One. 2019; 14(6):e0216533.
PMID: 31166987
PMC: 6550445.
DOI: 10.1371/journal.pone.0216533.
Canadian vaccine research networks: Vaccine safety resources for Canada.
McCarthy J, Halperin S, Bettinger J, Langley J, Crowcroft N, Deeks S
Can Commun Dis Rep. 2018; 41(Suppl 1):18-23.
PMID: 29769957
PMC: 5868603.
DOI: 10.14745/ccdr.v41is1a04.
The appropriateness of the use of influenza vaccines: Recommendations from the latest seasons in Italy.
Bonanni P, Boccalini S, Zanobini P, Dakka N, Lorini C, Santomauro F
Hum Vaccin Immunother. 2017; 14(3):699-705.
PMID: 29059004
PMC: 5861775.
DOI: 10.1080/21645515.2017.1388480.
Consultation with registered dietitian to prevent accidental reactions to food: insight from an egg allergy influenza vaccination cohort.
Begin P, Filion C, Graham F, Lacombe-Barrios J, Paradis J, Paradis L
Eur J Clin Nutr. 2016; 71(2):287-289.
PMID: 28000691
DOI: 10.1038/ejcn.2016.241.
Safety of live attenuated influenza vaccine in young people with egg allergy: multicentre prospective cohort study.
Turner P, Southern J, Andrews N, Miller E, Erlewyn-Lajeunesse M
BMJ. 2015; 351:h6291.
PMID: 26645895
PMC: 4673102.
DOI: 10.1136/bmj.h6291.
Safety of influenza vaccination in children with allergic diseases.
Yang H
Clin Exp Vaccine Res. 2015; 4(2):137-44.
PMID: 26273572
PMC: 4524898.
DOI: 10.7774/cevr.2015.4.2.137.
Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015-16 Influenza Season.
Grohskopf L, Sokolow L, Olsen S, Bresee J, Broder K, Karron R
MMWR Morb Mortal Wkly Rep. 2015; 64(30):818-25.
PMID: 26247435
PMC: 5779578.
DOI: 10.15585/mmwr.mm6430a3.
Vaccination in children with allergy to non active vaccine components.
Franceschini F, Bottau P, Caimmi S, Crisafulli G, Lucia L, Peroni D
Clin Transl Med. 2015; 4:3.
PMID: 25852819
PMC: 4384976.
DOI: 10.1186/s40169-014-0043-0.
Safety of live attenuated influenza vaccine in atopic children with egg allergy.
Turner P, Southern J, Andrews N, Miller E, Erlewyn-Lajeunesse M
J Allergy Clin Immunol. 2015; 136(2):376-81.
PMID: 25684279
PMC: 4534767.
DOI: 10.1016/j.jaci.2014.12.1925.
Increasing the use of influenza vaccines in children with egg allergy.
Hui C
Paediatr Child Health. 2015; 19(10):553-4.
PMID: 25587236
PMC: 4276392.
Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) -- United States, 2014-15 influenza season.
Grohskopf L, Olsen S, Sokolow L, Bresee J, Cox N, Broder K
MMWR Morb Mortal Wkly Rep. 2014; 63(32):691-7.
PMID: 25121712
PMC: 4584910.
Vaccine allergies.
Chung E
Clin Exp Vaccine Res. 2014; 3(1):50-7.
PMID: 24427763
PMC: 3890451.
DOI: 10.7774/cevr.2014.3.1.50.
IgA attenuates anaphylaxis and subsequent immune responses in mice: possible application of IgA to vaccines.
Yamaki K, Nakashima T, Miyatake K, Ishibashi Y, Ito A, Kuranishi A
Immunol Res. 2013; 58(1):106-17.
PMID: 24366664
DOI: 10.1007/s12026-013-8478-8.
